FDA Sentinel System’s Coronavirus (COVID-19) Activities

Project Title FDA Sentinel System’s Coronavirus (COVID-19) Activities
Description

FDA’s Sentinel System is engaged in numerous activities to protect and promote public health during the COVID-19 pandemic, ranging from monitoring the use of drugs, describing the course of illness among hospitalized patients, and evaluating the treatment impact of therapies actively being used under real-world conditions. Descriptions of efforts led by the Center for Drug Evaluation and Research are detailed in the link below.

Link
Published Date
Thursday, July 23, 2020
Category
Spotlight
Scroll to Top